Histamine human immunoglobulin (Sinopharm Shanghai Plasma-Derived)
组织胺人免疫球蛋白（国药上海血液制品）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHistamine human immunoglobulin (Sinopharm Shanghai Plasma-Derived)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1998/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A